We use cookies to ensure the best user experience and to serve tailored advertising. To learn more about our cookies and how to manage them, please visit our cookie policy

I AGREE
Close icon

Personalise what you see on this page.

Choose from the options below. We'll show you information based on your current location as default.

I'M FROM

  • United States
Please select so we can show the most relevant content.

LIVING IN

  • United States
Please select so we can show the most relevant content.

LOOKING FOR

  • Undergraduate courses
Please select so we can show the most relevant content.
Viewing as a student from United States living in United States interested in Undergraduate courses

Course options

  • Qualification

    MSc - Master of Science

  • Location

    Holloway

  • Study mode

    Full time

  • Start date

    SEP-21

  • Duration

    1 year

Course summary

Why study this course?

Our Cancer Immunotherapy master's will teach you about conventional cancer therapies including surgery, radiation and chemotherapy. You’ll have access to highly qualified researchers and teachers in pharmacology and immunology, as well as those from our Cellular and Molecular Immunology Research Centre. We’ll encourage you to join professional societies so you can improve your CV and build upon the impressive skills you’ll already have developed from research projects on the course. By the end of this postgraduate course, you’ll come to understand why investigators and oncologists now believe immunotherapy combined with pharmacological treatments will soon provide curative therapies that can give patients a new lease of life.

More about this course

The Cancer Immunotherapy MSc will introduce you to the advancement of treatments that are fighting to prolong the lives of cancer patients. Cancer is increasing worldwide, and by 2030 there are expected to be 22 million new cases per year. By the end of this course, you’ll be ready for employment as a professional who can help to tackle this global challenge.

We’ll provide you with an in-depth understanding of the molecular targets at which the different classes of anticancer drugs are aimed, as well as the current evolution of drug therapies. This will help you review the biology of cancer, taking pathological considerations into account, and the molecular changes within cells which are associated with the progression of the disease.

You’ll enhance your intellectual and practical skills necessary for the collection, analysis, interpretation and understanding of scientific data. This means you’ll cover new areas in immunotherapy as well as existing pharmacological therapies including (but not limited to) monoclonal antibodies in cancer therapy and prevention; DNA vaccines against cancer; adoptive T cell therapy; dendritic cell vaccines; microbial causes of cancer; adjuvant development for vaccines; epigenetics and cancer; immuno-chemotherapy; dendritic cell vaccine development; the ageing immune system and immunotherapy; natural killer cells/tumour-associated macrophages and cancer immunotherapy and Exosomes and Microvesicles (EMVs) in cancer therapy and diagnosis.

The teaching is delivered by highly-qualified researchers and teachers in pharmacology and immunology, including those from our Cellular and Molecular Immunology Research Centre. Skills gained from research projects will be highly marketable in industry, academia and the National Health Service (NHS), and you’ll also be encouraged to join the British Society of Immunology and the International Society of Extracellular Vesicles.

After the course

As a graduate of this course, you’ll be well prepared to work for companies that are developing cancer immunotherapies. Such companies include global biopharmaceutical company Bristol-Myers Squibbs, MERCK, AstraZeneca and Roche. There are also an an ever-growing number of start-up companies that are tackling cancer, including Vyriad, UNUM Therapeutics and Alpine Immune Sciences.

You’ll also have ample opportunity for future postgraduate study within the School of Human Sciences and the Cellular and Molecular Immunology Research Centre at the MPhil/PhD level, as well as research opportunities with partners within the UK, Europe and the rest of the world.

Tuition fees

Students living in United States
(international fees)

£ 13,750per year

Tuition fees shown are for indicative purposes and may vary. Please check with the institution for most up to date details.

University information

London Metropolitan University

  • University League Table

    118th

  • Campus address

    London Metropolitan University, Admissions Office, 166-220 Holloway Road, City of London, N7 8DB, England

Both campuses are in the heart of London, arguably the best city in the world for university students.
London Met is home to a hugely diverse community, with students from more than 140 different nationalities.
The dedicated international team organises induction events and can advise on immigration issues including visas, family and dependants, and work opportunities.

Is this page useful?

Yes No

Sorry about that...

HOW CAN WE IMPROVE IT?

SUBMIT

Thanks for your feedback!